Related Experiment Video
Updated: Aug 17, 2026

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
Epigallocatechin-3-gallate protects sepsis-induced myocardial dysfunction by inhibiting the nuclear factor-κB
Bei Chen1, Ya-Fei Li2, Zhang Fang1
1Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu Province, China.
Insights
Epigallocatechin-3-gallate (EGCG) from green tea protects against sepsis-induced myocardial dysfunction. EGCG reduces inflammation and apoptosis by inhibiting the TLR4/NF-κB pathway, offering potential treatment for heart damage during sepsis.
Area of Science:
- Cardiology
- Pharmacology
- Molecular Biology
Background:
- Sepsis-induced myocardial dysfunction (SIMD) is a life-threatening complication with limited therapeutic options.
- Epigallocatechin-3-gallate (EGCG), a green tea compound, shows promise for cardiovascular applications.
Purpose of the Study:
- To investigate EGCG's efficacy in preventing lipopolysaccharide (LPS)-induced myocardial dysfunction.
- To elucidate the molecular mechanisms underlying EGCG's cardioprotective effects.
Main Methods:
- Echocardiography assessed cardiac systolic function.
- TUNEL staining evaluated cardiomyocyte apoptosis.
- Western Blot and qRT-PCR analyzed inflammatory factors, apoptosis-related proteins, and cardiac markers.
Main Results:
- EGCG improved LPS-induced cardiac dysfunction and enhanced left ventricular systolic function.
- EGCG inhibited LPS-induced TLR4 upregulation and the IκBα/NF-κB/p65 signaling pathway.
- EGCG reduced cardiomyocyte apoptosis and myocarditis.
Conclusions:
- EGCG exerts anti-inflammatory and anti-apoptotic effects against SIMD.
- EGCG's protective mechanism involves inhibiting the TLR4/NF-κB signaling pathway.
- EGCG represents a potential therapeutic agent for preventing and treating SIMD.
Abstract:
Sepsis-induced myocardial dysfunction (SIMD) has become one of the most lethal complications of sepsis, while the treatment was limited by a shortage of pertinent drugs. Epigallocatechin-3-gallate (EGCG) is the highest content of active substances in green tea, and its application in cardiovascular diseases has broad prospects. This study was conducted to test the hypothesis that EGCG was able to inhibit lipopolysaccharide (LPS) induced myocardial dysfunction and investigate the underlying molecular mechanisms. The cardiac systolic function was assessed by echocardiography. The cardiomyocyte apoptosis was determined by TUNEL staining. The expression of inflammatory factors and apoptosis-related protein, cardiac markers were examined by Western Blot and qRT-PCR. EGCG effectively improve LPS-induced cardiac function damage, enhance left ventricular systolic function, and restore myocardial cell vitality. It can effectively inhibit the upregulation of TLR4 expression induced by LPS and inhibit IκB α/NF- κB/p65 signaling pathway, thereby inhibiting cardiomyocyte apoptosis and improving myocarditis. In conclusion, EGCG protects against SIMD through anti-inflammatory and anti-apoptosis effects; it was mediated by the inhibition of the TLR4/NF-κB signal pathway. Our results demonstrated that EGCG might be a possible medicine for SIMD prevention and treatment.
Related Concept Videos
Cell Specific Gene Expression
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
G-Protein Gated Ion Channels
Sensory organs,...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy

